0001828318-26-000046
SEC filingEnovix Corporation held its 2026 Annual Meeting, with shareholders electing eight directors, approving advisory executive compensation, and ratifying Deloitte & Touche as auditor.
The 8-K reports routine annual meeting results with no material surprises. All proposals passed with strong support, reflecting shareholder alignment with board and auditor selection.